Invention Grant
US09278921B2 Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine
有权
（3S.3S'）4,4'-二硫代二烷基双（3-氨基丁烷-1-磺酸）与L-赖氨酸的结晶相
- Patent Title: Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine
- Patent Title (中): （3S.3S'）4,4'-二硫代二烷基双（3-氨基丁烷-1-磺酸）与L-赖氨酸的结晶相
-
Application No.: US14437343Application Date: 2013-10-22
-
Publication No.: US09278921B2Publication Date: 2016-03-08
- Inventor: Fabrice Balavoine , Jean-Marie Schneider , Gérard Coquerel , Nicolas Couvrat
- Applicant: Quantum Genomics
- Applicant Address: FR Massy
- Assignee: Quantum Genomics
- Current Assignee: Quantum Genomics
- Current Assignee Address: FR Massy
- Agency: Dickstein Shapiro LLP
- Priority: EP12306307 20121022
- International Application: PCT/EP2013/072028 WO 20131022
- International Announcement: WO2014/064077 WO 20140501
- Main IPC: C07C323/66
- IPC: C07C323/66 ; C07C229/26 ; A61K31/145 ; A61K47/18
Abstract:
The present invention relates to a new crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and its use, particularly in the pharmaceutical industry, and to processes for preparation thereof. The invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and to the therapeutic or prophylactic use of such crystalline phase and compositions comprising the same.
Public/Granted literature
- US20150284325A1 CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE Public/Granted day:2015-10-08
Information query
